Présentation de l'entreprise
iTonic Holdings Ltd., operating under the ticker PTHL, functions as a healthcare solutions provider dedicated to the development and commercialization of specialized treatment software and devices for brachytherapy. This medical device sector focuses on delivering proprietary technologies for radioactive particle implantation, a form of radiotherapy utilized to treat cancer patients by placing radioactive sources directly within the body. The company currently maintains a market capitalization of $22.30M, generates an annual revenue of $305,215, and employs a workforce of 10 individuals. These valuation and revenue figures indicate that iTonic Holdings Ltd. operates as a micro-cap entity with a very limited market footprint, suggesting it is in an early stage of commercialization or a niche position within the broader medical device industry where scale is significantly smaller than established peers.
Santé financière
The financial performance of iTonic Holdings Ltd. is characterized by a trailing twelve-month revenue of $305,215, which contrasts sharply with a net income of $-2,412,952 and an EBITDA of $-2,523,650. The substantial negative net income relative to the positive revenue reveals a cost structure where operating expenses far exceed sales, indicating significant burn rates typical of companies in the R&D or commercialization phase. The company's free cash flow stands at $-2,674,562, which signifies a lack of financial flexibility and an ongoing reliance on external capital sources to fund operations rather than generating internal liquidity. Profitability is further underscored by a gross margin of 82.9%, which suggests strong pricing power or low cost of goods sold, yet this is negated by an operating margin of -3081.9% and a profit margin of 0.0%, highlighting severe inefficiencies or one-time costs impacting the bottom line. In terms of solvency, the company holds $3.21M in cash against a debt obligation of $139,595, resulting in a debt-to-equity ratio of 2.95, which implies a leveraged balance sheet despite the significant cash reserves available. Liquidity is robustly supported by a current ratio of 11.69, indicating that the company possesses more than eleven times the current assets necessary to cover its short-term liabilities. Return metrics are deeply negative, with a return on equity of -101.6% and a return on assets of -49.0%, revealing that management has not yet achieved effective capital deployment to generate value for shareholders or optimize asset utilization.
Évaluation de la valorisation
Valuation metrics for iTonic Holdings Ltd. are difficult to interpret using traditional multiples due to the lack of earnings, as both the trailing P/E ratio and forward P/E ratio are N/A. The absence of these earnings-based multiples implies that the market cannot value the stock based on expected earnings trajectory or historical profitability, forcing reliance on alternative valuation frameworks. The price-to-book ratio is recorded at 3.25, which indicates that the market is pricing the company at a significant premium over its net asset value, a common phenomenon for micro-cap firms with intangible assets or high growth potential that are not yet realized. Alternative valuation indicators such as the price-to-sales ratio of 73.07 and the EV/EBITDA of -2.90 suggest that the stock is priced based on revenue potential rather than profitability, reflecting high expectations for future commercial success despite current losses. The stock has exhibited extreme volatility within its trading range, with a 52-week high of $32.00 and a 52-week low of $0.39, meaning the current price sits significantly below the recent high. The beta value is N/A, which precludes a direct comparison of price volatility relative to the broader market but often suggests that small-cap stocks like this one can experience disproportionate movements independent of broader market indices.
Growth & Income
Revenue growth for the company has contracted by -67.9% year-over-year, while earnings growth is N/A due to the lack of profitable earnings to track. Since earnings are negative, there is no positive earnings growth to outpace revenue growth, indicating that the company is not yet in a sustainable expansion phase where profitability scales with revenue. As a non-dividend payer, the company does not distribute a dividend yield or a payout ratio, as both metrics are N/A or 0.0%, meaning the company reinvests its minimal cash flows and raises capital to fund its operations and product development rather than returning cash to shareholders. The overall growth and income profile of iTonic Holdings Ltd. is defined by significant revenue contraction and a complete absence of dividend income, positioning the investment entirely on the potential for future business model validation and commercial scaling.